Heron Therapeutics
HRTX
Heron Therapeutics (HRTX) news
Recent news
Heron Therapeutics Inc: H.C. Wainwright cuts to neutral from buy
AInvest Wire · Aug 11, 2026Heron Therapeutics withdrawing previously issued YR guidance
AInvest Wire · Aug 10, 2026Heron Therapeutics Q2 EPS USD -0.03
AInvest Wire · Aug 10, 2026HRTX 2Q loss/share 3.0c, est. loss/share 0.50c (2 est.)
AInvest Wire · Aug 10, 2026HRTX 2Q net product sales $37.7M, est. $42.2M (2 est.)
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.